EVELYN STEIN: Open Payments
NPI 1134759418 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,892 in 310 payments from 20 companies in 2025. Trend: 2023 $3,349 · 2024 $6,015 · 2025 $7,892
Food & beverage: $5,206Consulting: $2,325Education: $284Speaker / faculty: $77
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 56 | $2,969 |
| Regeneron Healthcare Solutions, Inc. | 17 | $617 |
| ABBVIE INC. | 44 | $604 |
| Galderma Laboratories, L.P. | 26 | $509 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $447 |
| Incyte Corporation | 19 | $412 |
| Janssen Biotech, Inc. | 17 | $410 |
| LEO Pharma Inc. | 20 | $353 |
| Lilly USA, LLC | 15 | $244 |
| Novartis Pharmaceuticals Corporation | 11 | $231 |
Products named: CIBINQO, DUPIXENT, RINVOQ, NEMLUVIO, OPZELURA, TREMFYA, ADBRY, Sotyktu.
Industry payments across RI — which companies pay providers there.
